StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > House Positions for C:SZLS for yesterday and today

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jul 07, 2021 9:21pm

143 Views

Post# 33510159

RE:RE:RE:House Positions for C:SZLS for yesterday and today

Haha, when the "#1 Top-Ranked Research in Canada" is on the buy (with real money) and the braying bashers don't have any material grievances, but dance and bray and crow their empty inferences all day... well...
I couldn't be happer to be a 1% owner of this company, lol.
Why, the paid underminers are already talking takeover price...
2 Billion? Really? That's $25/share, lol!
Big Pharma can do better than that!
Our diagnostic is better than Grail's and everybody knows it.
GLTA who are way ahead of the curve!
(The wait is longer, but the payoff's better....*wink!)